OncoNext™ Risk – Breast
OncoNext ™ Risk Breast is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of breast cancer. The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.
OncoNext™ Risk – Colon
OncoNext™ Risk Colon is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of colorectal cancer or Familial Adenomatous Polyposis. The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.
OncoNext™ Risk – Prostate
OncoNext™ Risk Prostate is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of Prostate cancer. The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.
OncoNext™ Risk – Oncoscreening Complete
OncoNext ™ Risk OncoScreening Complete is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to hereditary cancers, including: Breast Cancer, Ovarian / Uterus Cancer, Colorectal Cancer, Stomach Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer (Melanoma), Brain Cancer, Kidney Cancer and Pheochromocytoma / Paraganglioma. […]
